Epidemiology of Primary Hyperparathyroidism

Melton, 2002, The epidemiology of primary hyperparathyroidism in North America, J Bone Miner Res, 17, N12 Bilezikian, 2009, Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Third International Workshop, J Clin Endocrinol Metab, 94, 335, 10.1210/jc.2008-1763 2005 Söreide, 1997, Survival after surgical treatment for primary hyperparathyroidism, Surgery, 122, 1117, 10.1016/S0039-6060(97)90216-6 Wermers, 1998, Survival after the diagnosis of primary hyperparathyroidism: a population-based study, Am J Med, 104, 115, 10.1016/S0002-9343(97)00270-2 Sivula, 1996, Long-term health risk of primary hyperparathyroidism: the effect of surgery, Ann Intern Med, 28, 95, 10.3109/07853899609092932 Lafferty, 1989, Primary hyperparathyroidism: a review of the long-term surgical and nonsurgical morbidities as basis for a rational approach to treatment, Arch Intern Med, 149, 789, 10.1001/archinte.1989.00390040031006 Palmer, 1987, Mortality after surgery for primary hyperparathyroidism: a follow-up of 441 patients operated on from 1956 to 1979, Surgery, 102, 1 Ronni-Sivula, 1985, Causes of death in patients previously operated on for primary hyperparathyroidism, Ann Chir Gynaecol, 74, 13 Hedbäck, 1990, Premature death in patients operated on for primary hyperparathyroidism, World J Surg, 14, 829, 10.1007/BF01670531 Ljunghall, 1991, Longitudinal studies of mild primary hyperparathyroidism, J Bone Miner Res, 6, S111 Hedbäck, 1991, The influence of surgery on the risk of death in patients with primary hyperparathyroidism, World J Surg, 15, 399, 10.1007/BF01658740 Nilsson, 2002, Clinical presentation of primary hyperparathyroidism in Europe-nationwide cohort analysis on mortality from nonmalignant causes, J Bone Miner Res, 17, N68 Hedbäck, 1998, Increased risk of death from primary hyperparathyroidism-an update, Eur J Clin Invest, 28, 271, 10.1046/j.1365-2362.1998.00289.x Hedbäck, 2002, Cardiovascular disease, hypertension and renal function in primary hyperparathyroidism, J Intern Med, 251, 476, 10.1046/j.1365-2796.2002.00984.x Øgard, 2004, Increased mortality in patients hospitalized with primary hyperparathyroidism during the period 1977-1993 in Denmark, World J Surg, 28, 108, 10.1007/s00268-003-7046-0 Yu, 2011, A record linkage study of outcomes in patients with mild primary hyperparathyroidism: the Parathyroid Epidemiology and Audit Research Study (PEARS), Clin Endocrinol (Oxf), 75, 169, 10.1111/j.1365-2265.2010.03958.x Yu, 2010, Increased mortality and morbidity in mild primary hyperparathyroid patients. The Parathyroid Epidemiology and Audit Research Study (PEARS), Clin Endocrinol (Oxf), 73, 30 Popovic, 1999 Haupt, 1977 Graham, 1977 Palmér, 1987, Patients with primary hyperparathyroidism operated on over a 24-year period: temporal trends in clinical and laboratory findings, J Chronic Dis, 40, 121, 10.1016/0021-9681(87)90063-4 Adami, 1984, Primary hyperparathyroidism, 112 Wermers, 2006, Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993-2001: an update on the changing epidemiology of the disease, J Bone Miner Res, 21, 171, 10.1359/JBMR.050910 Wermers, 1997, The rise and fall of primary hyperparathyroidism: a population-based study in Rochester, Minnesota, 1965-1992, Ann Intern Med, 126, 433, 10.7326/0003-4819-126-6-199703150-00003 Heath, 1980, Primary hyperparathyroidism: incidence, morbidity, and potential economic impact on a community, N Engl J Med, 302, 189, 10.1056/NEJM198001243020402 Adami, 2002, Epidemiology of primary hyperparathyroidism in Europe, J Bone Miner Res, 17, N18 Haff, 1970, Primary hyperparathyroidism: changing clinical, surgical and pathological aspects, Ann Surg, 171, 85, 10.1097/00000658-197001000-00013 Preisman, 1971, A plethora of primary hyperparathyroidism, Arch Surg, 103, 12, 10.1001/archsurg.1971.01350070038007 Aitken, 1975, The effect of multiphasic biochemical screening on the diagnosis of primary hyperparathyroidism, Aust N Z J Med, 5, 224, 10.1111/j.1445-5994.1975.tb04572.x Trigonis, 1983, Primary hyperparathyroidism. Changing trends over fifty years, Acta Chir Scand, 149, 675 Mundy, 1980, Primary hyperparathyroidism: changes in the pattern of clinical presentation, Lancet, 1, 1317, 10.1016/S0140-6736(80)91783-3 Lawson, 1996, Primary hyperparathyroidism in paediatric hospital, QJM, 89, 921, 10.1093/qjmed/89.12.921 Loh, 1998, Clinical profile of primary hyperparathyroidism in adolescents and young adults, Clin Endocrinol (Oxf), 48, 435, 10.1046/j.1365-2265.1998.00329.x Hundahl, 1998, Perspective: National Cancer Institute summary report about estimated exposures and thyroid doses received from iodine 131 in fallout from Nevada atmospheric nuclear bomb tests, CA Cancer J Clin, 48, 285, 10.3322/canjclin.48.5.285 Fujiwara, 1992, Hyperparathyroidism among atomic bomb survivors in Hiroshima, Radiat Res, 130, 372, 10.2307/3578384 Burke, 2005, Long-term trends in thyroid carcinoma: a population-based study in Olmsted County, Minnesota, 1935-1999, Mayo Clin Proc, 80, 753, 10.1016/S0025-6196(11)61529-2 Saliba, 2012, Vitamin D status in primary hyperparathyroidism, Eur J Intern Med, 23, 88, 10.1016/j.ejim.2011.07.008 Shlapack, 2012, Normocalcemic primary hyperparathyroidism characteristics and clinical significance of an emerging entity, Am J Med Sci, 343, 163, 10.1097/MAJ.0b013e31823bbb9b Boonstra, 1971, Serum calcium survey for hyperparathyroidism: results in 50,000 clinic patients, Am J Clin Pathol, 55, 523, 10.1093/ajcp/55.5.523 Christensson, 1976, Prevalence of hypercalcaemia in a health screening in Stockholm, Acta Med Scand, 200, 131, 10.1111/j.0954-6820.1976.tb08208.x Jorde, 2000, Primary hyperparathyroidism detected in a health screening: the Tromsø study, J Clin Epidemiol, 53, 1164, 10.1016/S0895-4356(00)00239-0 Sorva, 1992, Serum ionized calcium and the prevalence of primary hyperparathyroidism in age cohorts of 75, 80, and 85 years, J Intern Med, 231, 309, 10.1111/j.1365-2796.1992.tb00540.x Lundgren, 1997, Population-based screening for primary hyperparathyroidism with serum calcium and parathyroid hormone values in menopausal women, Surgery, 121, 287, 10.1016/S0039-6060(97)90357-3 Almqvist, 2011, Increased markers of inflammation and endothelial dysfunction in patients with mild primary hyperparathyroidism, Scand J Clin Lab Invest, 71, 139, 10.3109/00365513.2010.543694 Rosa, 2011, Pulse wave velocity in primary hyperparathyroidism and effect of surgical therapy, Hypertens Res, 34, 296, 10.1038/hr.2010.232 Marini, 2010, Reduced coronary flow reserve in patients with primary hyperparathyroidism: a study by G-SPECT myocardial perfusion imaging, Eur J Nucl Med Mol Imaging, 37, 2256, 10.1007/s00259-010-1599-6 Hagström, 2010, Plasma parathyroid hormone and risk of congestive heart failure in the community, Eur J Heart Fail, 12, 1186, 10.1093/eurjhf/hfq134 Brunaud, 2009, Serum aldosterone is correlated positively to parathyroid hormone (PTH) levels in patients with primary hyperparathyroidism, Surgery, 146, 1035, 10.1016/j.surg.2009.09.041 Sosa, 1998, Cost implications of different surgical management strategies for primary hyperparathyroidism, Surgery, 124, 1028, 10.1067/msy.1998.91829 Zanocco, 2011, Cost-effectiveness of parathyroidectomy for primary hyperparathyroidism, Endocr Pract, 17, 1, 10.4158/EP10311.RA Stock, 2001, Medical management of primary hyperparathyroidism, 459 Denham, 1998, Cost-effectiveness of preoperative sestamibi scan for primary hyperparathyroidism is dependent solely upon the surgeon’s choice of operative procedure, J Am Coll Surg, 186, 293, 10.1016/S1072-7515(98)00016-7